跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIXIANA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIXIANA
Authorized
STANDARD
LIXIANA
servier canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9396f02f6da29214
Company
servier canada inc
Type
Standard
Approval Details
Approval Id
9396f02f6da29214
Drug Approval Canada Name
LIXIANA
Product Name
LIXIANA
Status
Marketed
Status Date
2017-04-25
Original Market Date
2017-04-25
Din
02458659
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.04.14
Atc Original
B01AF03 EDOXABAN
Atc Name
b 01 af 03
Aig Number
0158530002
Company Name
servier canada inc
Company Address
270, 3224 Avenue Jean-Béraud, Laval, Quebec, Canada, H7T 2S4
Active Ingredients
EDOXABAN (EDOXABAN TOSYLATE MONOHYDRATE)
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9396f02f6da29214
Type
Standard
Back to Health Canada Approvals